News & Updates

Show Multimedia Only
ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

02 Dec 2024
Palbociclib vs abemaciclib: How to choose the right treatment for breast cancer patients

Palbociclib vs abemaciclib: How to choose the right treatment for breast cancer patients

01 Dec 2024